As of 2025-05-17, the Fair Value of VistaGen Therapeutics Inc (VTGN) is -8.20 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 2.46 USD, the upside of VistaGen Therapeutics Inc is -433.15%.
With the market price of 2.46 USD and our fair value calculation, VistaGen Therapeutics Inc (VTGN) is not a good investment. Investing in VTGN stocks now will result in a potential loss of 433.15%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 5Y Avg | |
| Net income | -20.77 | -17.93 | -47.76 | -59.25 | -29.36 | -35.01 |
| YoY growth | 15.53% | 13.67% | -166.37% | -24.06% | 50.44% | -22.15% |
| Market Cap (mil) | 71.00 |
| P/E | |
| Forward P/E |
| EPS | -1.64 |
| Avg earnings growth rate | -22.15% |
| TTM earnings | -47.30 |